DEXCOM, INC. Line of Credit Facility, Remaining Borrowing Capacity
DEXCOM, INC. (DXCM) had Line of Credit Facility, Remaining Borrowing Capacity of $191.30 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes
us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity · last filed 2026-07-30
- 2026-06-30: Line of Credit Facility, Remaining Borrowing Capacity $191.30M.
- 2026-03-31: Line of Credit Facility, Remaining Borrowing Capacity $191.20M.
- 2025-12-31: Line of Credit Facility, Remaining Borrowing Capacity $192.10M.
- 2025-09-30: Line of Credit Facility, Remaining Borrowing Capacity $192.30M.
| Period end | Line of Credit Facility, Remaining Borrowing Capacity |
|---|---|
| 2026-06-30 | $191.30M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $191.20M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $192.10M 10-K · filed 2026-02-12 |
| 2025-09-30 | $192.30M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $192.30M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $192.30M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $192.30M 10-K · filed 2025-02-18 |
| 2024-09-30 | $192.40M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $192.40M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $192.40M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $192.60M 10-K · filed 2024-02-08 |
| 2023-09-30 | $192.70M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $192.70M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $192.70M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $192.70M 10-K · filed 2023-02-09 |
| 2022-09-30 | $192.70M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $192.70M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $192.70M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $192.70M 10-K · filed 2022-02-14 |
| 2021-09-30 | $193.60M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $193.60M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $193.60M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $193.70M 10-K · filed 2021-02-11 |
| 2020-09-30 | $194.60M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $194.60M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $194.60M 10-Q · filed 2020-04-28 |
| 2019-12-31 | $195.60M 10-K · filed 2020-02-13 |
| 2019-09-30 | $195.60M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $195.60M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $195.60M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $195.60M 10-K · filed 2019-02-21 |
| 2018-09-30 | $195.60M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $195.60M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $195.60M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $200.00M 10-K · filed 2018-02-27 |
| 2017-09-30 | $200.00M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $200.00M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $125.00M 10-Q · filed 2017-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |